ALDH1A1 and breast cancer: They found that ALDH1A1 decreased the intracellular pH in breast cancer cells, in order to promote the phosphorylation of TAK1, activate the NFκB signal pathway, and increase the secretion of GM-CSF, and this led to myeloid-derived suppressor cell expansion and immunosuppression (89).